Who should have an imaging screening test?

Lung screening is targeted to a defined risk group

The USPSTF recommends annual low-dose CT lung screening for adults aged 50 to 80 who have at least a 20 pack-year smoking history and currently smoke or quit within the past 15 years. A pack-year describes average packs smoked per day multiplied by years of smoking. The recommendation also includes stopping conditions related to time since quitting and health or ability to undergo curative treatment. Eligibility is therefore more specific than age alone. Discuss the potential benefits and harms with a clinician; a screening appointment is different from investigating a new respiratory symptom.

A useful screening test must offer more than early detection

Finding an abnormality earlier is not, by itself, proof that a screening program improves health. Screening can produce false alarms, miss disease or identify a condition that would never have caused harm. These outcomes can lead to further procedures, anxiety and treatment. Evidence-based recommendations consider those effects alongside potential benefit in a defined population. Before choosing a scan, ask who the test is intended for, what outcome it is meant to improve and what happens after an abnormal result. A broad scan package should not be assumed to have the same evidence as a targeted screening program.

Consider what happens after an abnormal result

Before choosing a screening examination, ask what finding would lead to repeat imaging, specialist assessment or another procedure. A screening pathway includes these later steps, not only the first appointment. Understanding them helps you weigh potential benefit against the chance of an uncertain finding that needs more investigation.

Ask who will explain the result and coordinate follow-up. A report delivered without a responsible clinician can leave important questions unresolved. If you are arranging imaging yourself after seeing an advertisement, first discuss whether the examination is appropriate for your risk profile and whether a doctor’s order is needed.

A normal scan is not a complete health certificate

Each examination has a defined purpose and limits. A normal result does not exclude every disease or replace routine care. Screening also differs from investigating symptoms: the presence of a new clinical problem can change which test is appropriate and how urgently it is needed.

At Advantis, a doctor’s order is required for every scan. Bring the specific recommendation to scheduling so the team can confirm the study and location. For lung screening or whole-body MRI questions, discuss the individual evidence and follow-up plan with your clinician before treating an imaging package as a general wellness check.

Screening and investigating symptoms differ

A screening examination looks for disease before symptoms develop. A diagnostic study investigates a clinical concern. Tell your clinician which situation applies; a screening package should not delay the assessment of symptoms.

Ask about benefit and follow-up

Ask who benefits from the proposed test, what an abnormal result could lead to, and how often it would be repeated. Discuss your age, medical and family history, and any previous screening. Consider the full follow-up pathway as well as the first scan.

Benefit, false alarms and missed findings

Screening decisions consider more than whether a scanner can produce detailed images. A useful discussion includes what the examination can detect, what it can miss and what might happen if it finds something uncertain. Further assessment may involve another scan, a procedure, cost or waiting. Ask how those possibilities compare with the expected benefit for your own risk group. A test suitable for one group may not be helpful as a general screening offer.

Choose a program with a next step

For a screening test that is appropriate, identify the clinician who will review the result and the office responsible for follow-up. Ask whether repeat screening is expected and how the interval will be decided. Save the report and any recommended action so the plan does not end with a completed scan. If your health or symptoms change, contact the clinician rather than relying on the date of the next routine screen.

Whole-body scanning is not an all-clear

Routine whole-body MRI for people without symptoms or relevant risk factors is not supported by sufficient evidence for an ACR recommendation. Unexpected findings can lead to additional tests. Discuss the reason for scanning with your clinician before purchasing an examination.

Scheduling an ordered examination

Once your clinician has recommended a specific study, Advantis can confirm availability and preparation. Read the full order to the scheduling team. Ask about costs or coverage and how the report will get back to the clinician responsible for follow-up.

Plan beyond the first result

Before scheduling, ask who will interpret the finding in the context of your risk and who will arrange any recommended follow-up. Consider the time and costs associated with that pathway. A result needing further investigation is not automatically a diagnosis, but it should have a clear next step. Keep the responsible clinician’s details with the examination order.

Avoid combining unrelated screening promises

A broad package name may make several tests sound interchangeable or universally beneficial. Ask what each included examination is intended to detect, whether you meet its eligibility criteria and what it could change in your care. If you have symptoms, explain them to your clinician rather than treating a screening package as a replacement for assessment.

Frequently Asked Questions